SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-066854
Filing Date
2010-12-16
Accepted
2010-12-16 16:07:38
Documents
5
Period of Report
2010-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v205665_8k.htm 8-K 24416
2 v205665_ex99-1.htm EX-99.1 629
3 GRAPHIC v205665_ex99-1x1x1.jpg GRAPHIC 137089
4 GRAPHIC v205665_ex99-1x2x1.jpg GRAPHIC 161050
5 GRAPHIC v205665_ex99-1x3x1.jpg GRAPHIC 117032
  Complete submission text file 0001144204-10-066854.txt   599160
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 101256833
SIC: 2836 Biological Products, (No Diagnostic Substances)